Vascularization of repaired limb bone defects using chitosan-β-tricalcium phosphate composite as a tissue engineering bone scaffold

Yang,Le; Wang,Qinghua; Peng,Lihua; Yue,Hong; Zhang,Zhendong

doi:10.3892/mmr.2015.3653

Vascularization of repaired limb bone defects using chitosan-β-tricalcium phosphate composite as a tissue engineering bone scaffold

Authors:
- Le Yang
- Qinghua Wang
- Lihua Peng
- Hong Yue
- Zhendong Zhang
View Affiliations

Affiliations: Saint Petersburg State I.P. Pavlov Medical University, St. Petersburg 197101, Russia, Department of Orthopedics, Hukou County Hospital of Traditional Chinese Medicine, Hukou, Jiangxi 332500, P.R. China, Department of Orthopedics, The People's Hospital of Bishan County, Bishan, Chongqing 402760, P.R. China, Department of Orthopedics, Zibo Zhangdian Hospital of Traditional Chinese Medicine, Zibo, Shandong 255035, P.R. China, Department of Orthopedics, The 301 Military Hospital, Beijing 100853, P.R. China
Published online on: April 21, 2015 https://doi.org/10.3892/mmr.2015.3653
Pages: 2343-2347

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ensuring histocompatibility in the tissue engineering of bones is a complex issue. The aim of this study was to observe the feasibility of chitosan‑β‑tricalcium phosphate composite in repairing limb bone defects, and to evaluate the therapeutic effects on osteogenesis. Beagle mesenchymal stem cells (MSCs) were divided into an experimental group that was cultured with an injectable form of chitosan‑β‑tricalcium phosphate composite and a control group. The effect of the composite on bone tissue growth was evaluated by MTT assay. In addition, 12‑month‑old beagles were subjected to 15‑mm femur defects and subsequently implanted with scaffolds to observe the effects on osteogenesis and vascularization. The dogs were subdivided into two groups of five animals: Group A, which was implanted with scaffold‑MSC compounds, and Group B, which was implanted with scaffolds alone. The dogs were observed on the 2nd, 4th, 8th and 12th weeks post‑implantation. Scanning electron microscopy analysis revealed that the composite was compatible with MSCs, with similar outcomes in the control and experimental groups. MTT analysis additionally showed that the MSCs in the experimental group grew in a similar manner to those in the control group. The composite did not significantly affect the MSC growth or proliferation. In combination with MSCs, the scaffold materials were effective in the promotion of osteogenesis and vascularization. In conclusion, the chitosan‑β‑tricalcium phosphate composite was compatible with the MSCs and did not affect cellular growth or proliferation, therefore proving to be an effective injectable composite for tissue engineered bone. Simultaneous implantation of stem cells with a carrier composite proved to function effectively in the repair of bone defects.

View Figures

View References

1	Dimitriou R, Jones E, McGonagle D and Giannoudis PV: Bone regeneration: current concepts and future directions. BMC Med. 9:662011. View Article : Google Scholar : PubMed/NCBI
2	Bose S, Roy M and Bandyopadhyay A: Recent advances in bone tissue engineering scaffolds. Trends Biotechnol. 30:546–554. 2012. View Article : Google Scholar : PubMed/NCBI
3	Muschler GF, Nakamoto C and Griffith LG: Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am. 86-A:1541–1558. 2004.PubMed/NCBI
4	Muschler GF, Raut VP, Patterson TE, Wenke JC and Hollinger JO: The design and use of animal models for translational research in bone tissue engineering and regenerative medicine. Tissue Eng Part B Rev. 16:123–145. 2010. View Article : Google Scholar
5	Tasso R, Fais F, Reverberi D, Tortelli F and Cancedda R: The recruitment of two consecutive and different waves of host stem/progenitor cells during the development of tissue-engineered bone in a murine model. Biomaterials. 31:2121–2129. 2010. View Article : Google Scholar
6	Yeatts AB and Fisher JP: Bone tissue engineering bioreactors: dynamic culture and the influence of shear stress. Bone. 48:171–181. 2011. View Article : Google Scholar
7	Yilgor P, Tuzlakoglu K, Reis RL, Hasirci N and Hasirci V: Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. Biomaterials. 30:3551–3559. 2009. View Article : Google Scholar : PubMed/NCBI
8	Mouriño V and Boccaccini AR: Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds. J R Soc Interface. 7:209–227. 2010. View Article : Google Scholar :
9	Holzwarth JM and Ma PX: Biomimetic nanofibrous scaffolds for bone tissue engineering. Biomaterials. 32:9622–9629. 2011. View Article : Google Scholar : PubMed/NCBI
10	Yamada Y, Nakamura S, Ito K, et al: Injectable bone tissue engineering using expanded mesenchymal stem cells. Stem Cells. 31:572–580. 2013. View Article : Google Scholar
11	Bi ZG, Han XG, Fu CJ, Cao Y and Yang CL: Reconstruction of large limb bone defects with a double-barrel free vascularized fibular graft. Chin Med J (Engl). 121:2424–2428. 2008.
12	Noaman HH: Management of upper limb bone defects using free vascularized osteoseptocutaneous fibular bone graft. Ann Plast Surg. 71:503–509. 2013. View Article : Google Scholar : PubMed/NCBI
13	Jiang Q, Reddy N and Yang Y: Cytocompatible cross-linking of electrospun zein fibers for the development of water-stable tissue engineering scaffolds. Acta Biomater. 6:4042–4051. 2010. View Article : Google Scholar : PubMed/NCBI
14	Gyawali D, Nair P, Zhang Y, et al: Citric acid-derived in situ crosslinkable biodegradable polymers for cell delivery. Biomaterials. 31:9092–9105. 2010. View Article : Google Scholar : PubMed/NCBI
15	Kuo YC and Yeh CF: Effect of surface-modified collagen on the adhesion, biocompatibility and differentiation of bone marrow stromal cells in poly(lactide-co-glycolide)/chitosan scaffolds. Colloids Surf B Biointerfaces. 82:624–631. 2011. View Article : Google Scholar
16	Amini AR, Laurencin CT and Nukavarapu SP: Differential analysis of peripheral blood- and bone marrow-derived endo-thelial progenitor cells for enhanced vascularization in bone tissue engineering. J Orthop Res. 30:1507–1515. 2012. View Article : Google Scholar : PubMed/NCBI
17	Sun X, Su J, Bao J, et al: Cytokine combination therapy prediction for bone remodeling in tissue engineering based on the intracellular signaling pathway. Biomaterials. 33:8265–8276. 2012. View Article : Google Scholar : PubMed/NCBI
18	Zhao J, Luo C, Han W, Tu M, Zeng R, Cha Z and Zhou C: Fabrication and properties of poly(L-lactide)/hydroxyapatite/chitosan fiber ternary composite scaffolds for bone tissue engineering. J Polymer Eng. 32:283–289. 2012. View Article : Google Scholar
19	Pan L, Pei X, He R, Wan Q and Wang J: Multiwall carbon nanotubes/polycaprolactone composites for bone tissue engineering application. Colloids Surf B Biointerfaces. 93:226–234. 2012. View Article : Google Scholar : PubMed/NCBI
20	Higuita-Castro N, Gallego-Perez D, Pelaez-Vargas A, et al: Reinforced Portland cement porous scaffolds for load-bearing bone tissue engineering applications. J Biomed Mater Res B Appl Biomater. 100B:501–507. 2012. View Article : Google Scholar
21	Ji Y, Xu GP, Zhang ZP, Xia JJ, Yan JL and Pan SH: BMP-2/PLGA delayed-release microspheres composite graft, selection of bone participate diameters, and prevention of aseptic inflammation for bone tissue engineering. Ann Biomed Eng. 38:632–639. 2010. View Article : Google Scholar : PubMed/NCBI
22	Clarke SA, Walsh P, Maggs CA and Buchanan F: Designs from the deep: marine organisms for bone tissue engineering. Biotechnol Adv. 29:610–617. 2011. View Article : Google Scholar : PubMed/NCBI
23	Alge DL, Bennett J, Treasure T, Voytik-Harbin S, Goebel WS and Chu TM: Poly(propylene fumarate) reinforced dicalcium phosphate dihydrate cement composites for bone tissue engineering. J Biomed Mater Res A. 100:1792–1802. 2012. View Article : Google Scholar : PubMed/NCBI